Castle Biosciences (CSTL) Net Cash Flow (QoQ) (2018 - 2026)
Castle Biosciences (CSTL) Net Cash Flow (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn |
| 10 | Castle Biosciences | 919.57 Mn | 652.76 Mn | 79.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 96.89% |
| Mar 31, 2026 | -269.91% |
| Dec 31, 2025 | 838.10% |
| Sep 30, 2025 | 144.57% |
| Jun 30, 2025 | 75.16% |
| Mar 31, 2025 | -221.29% |
| Dec 31, 2024 | 163.66% |
| Sep 30, 2024 | 257.87% |
| Jun 30, 2024 | 116.51% |
| Mar 31, 2024 | -308.61% |
| Dec 31, 2023 | 263.79% |
| Sep 30, 2023 | 75.45% |
| Jun 30, 2023 | -133.14% |
| Mar 31, 2023 | 27.64% |
| Dec 31, 2022 | 91.92% |
| Sep 30, 2022 | -287.68% |
| Jun 30, 2022 | -73.90% |
| Mar 31, 2022 | 38.54% |
| Dec 31, 2021 | -549.83% |
| Sep 30, 2021 | 86.64% |